Yahoo
NYSE - Nasdaq Real Time Price USD

agilon health, inc. (AGL)

86.38 +1.47 (+1.74%)
As of 11:58:48 AM EST. Market Open.
AGL Q3 2026 earnings call
November 4, 2026 at 4:30 PM EST
Chart Range Bar
Loading chart for AGL
  • Previous Close 84.90
  • Open 86.12
  • Bid 85.72 x 10000
  • Ask 86.39 x 10000
  • Day's Range 83.78 - 86.99
  • 52 Week Range 7.48 - 133.04
  • Volume 49,121
  • Avg. Volume 255,268
  • Market Cap (intraday) 1.45B
  • Beta (5Y Monthly) 3.11
  • PE Ratio (TTM) --
  • EPS (TTM) -15.41
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 115.83
  • Zacks Rating Neutral

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

www.agilonhealth.com

856

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AGL
400.09%
S&P 500 (^GSPC)
11.37%

1-Year Return

AGL
332.32%
S&P 500 (^GSPC)
11.46%

3-Year Return

AGL
79.60%
S&P 500 (^GSPC)
76.58%

5-Year Return

AGL
86.06%
S&P 500 (^GSPC)
64.65%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.49B
Earnings 17.96M
Profit Margin 1.20%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
2B
-10.0%
-5.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

85.00
115.83 Average
86.38 Current
146.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/15/2026
Analyst Bernstein
Rating Action Upgrade
Rating Outperform
Price Action Raises
Price Target 86 -> 125

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.92%

  • Return on Assets (ttm)

    -9.61%

  • Return on Equity (ttm)

    -78.94%

  • Revenue (ttm)

    5.92B

  • Net Income Avi to Common (ttm)

    -251.22M

  • Diluted EPS (ttm)

    -15.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    185.63M

  • Total Debt/Equity (mrq)

    14.70%

  • Levered Free Cash Flow (ttm)

    -145.68M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: